11:15 AM EDT, 10/27/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Monday morning, rising 0.73% to 1,602.22 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech company Evaxion ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which advanced 7.2% and 4.6% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and internet advertising firm Criteo ( CRTO ) , which increased 2.9% and 1.8% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and 3D printer company Materialise (MTLS), which fell 1.6% and 1.5% respectively. They were followed by biotech company BioNTech(BNTX) and consumer goods company Unilever ( UL ) , which were down 0.5% each.

From the UK and Ireland, the gainers were led by biotech company Trinity Biotech ( TRIB ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which rose 6% and 4.5% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech company Autolus Therapeutics ( AUTL ) , which were up 2.5% and 2% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics ( SLN ) and alcoholic beverage company Diageo ( DEO ) , which dropped 2.8% and 1.2% respectively. They were followed by educational publisher Pearson (PSO) and oil and gas company Shell (SHEL), which were off 0.5% each.